NasdaqGM · Stocky rates: Cautious

Cronos Group Inc. Common Share (CRON)

$2.72 ▼ -3.20% as of 6 Aug, 13:26
59
/ 100
Neutral

What Stocky thinks

Cautious. Cronos shows decent growth momentum (65/100 Growth Compounder Score) but faces meaningful structural risk: nearly total reliance on Cronos GrowCo for cannabis supply under a fixed-price agreement expiring after four years with no renewal guarantee. At 28.9× forward P/E, valuation offers little margin of safety against supply disruption or margin compression—a critical vulnerability for a cannabis player with thin moats.

Compounder Score
65/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
63/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
41/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Cronos Group Inc. Common Share:

59
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 59/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

63
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Cronos Group Inc. Common Share (CRON) — frequently asked

Is Cronos Group Inc. Common Share (CRON) a good investment right now?

Stocky rates Cronos Group Inc. Common Share (CRON) at 59/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Cronos shows decent growth momentum (65/100 Growth Compounder Score) but faces meaningful structural risk: nearly total reliance on Cronos GrowCo for cannabis supply under a fixed-price agreement expiring after four years with no

What is CRON's Stocky Verdict?

CRON's current Stocky Verdict is 59/100, placing it in the "Cautious" band. This composite combines a 65/100 Compounder score, 63/100 Leadership, Moat rating, and analyst signal.

Does Cronos Group Inc. Common Share have a competitive moat?

Stocky hasn't finalised a Moat Score for Cronos Group Inc. Common Share yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Cronos Group Inc. Common Share's leadership aligned with shareholders?

Cronos Group Inc. Common Share scores 63/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to CRON?

Cronos Group Inc. Common Share's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Cronos Group Inc. Common Share.

This is just the surface. See the whole picture on Cronos Group Inc. Common Share.

Sign up free and unlock the full analysis on CRON — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering CRON — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for CRON.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how CRON changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to CRON?" · "Is CRON overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
59
/ 100 · Neutral

Or jump straight to the interactive dashboard for CRON in the app.